Brain proteomic changes by histone deacetylase inhibition after traumatic brain injury

BACKGROUND: Traumatic brain injury (TBI) is a leading cause of morbidity and mortality. There are currently no cytoprotective treatments for TBI. There is growing evidence that the histone deacetylase inhibitor valproic acid (VPA) may be beneficial in the treatment of TBI associated with hemorrhagic...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Trauma Surg Acute Care Open
Asıl Yazarlar: Pumiglia, Luke, Williams, Aaron M, Kemp, Michael T, Wakam, Glenn K, Alam, Hasan B, Biesterveld, Ben E
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMJ Publishing Group 2021
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7993337/
https://ncbi.nlm.nih.gov/pubmed/33880414
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/tsaco-2021-000682
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller